Exousia Bio, Inc. Proceeds from Notes Payable
Exousia Bio, Inc. (LMMY) reported Proceeds from Notes Payable of $0 for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-06-16.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-06-16
- Exousia Bio, Inc. proceeds from notes payable for the quarter ending 2026-02-28 was $0.00.
- Exousia Bio, Inc. proceeds from notes payable for the quarter ending 2025-11-30 was $0.00.
- Exousia Bio, Inc. proceeds from notes payable for the quarter ending 2025-08-31 was $0.00.
- Exousia Bio, Inc. proceeds from notes payable for the quarter ending 2025-02-28 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month |
|---|---|---|---|
| 2026-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-16 | $0.00 derived: sum of 2 quarters · filed 2026-06-16 | $0.00 10-Q · filed 2026-06-16 |
| 2025-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-17 | $0.00 10-Q · filed 2026-03-17 | |
| 2025-08-31 | $0.00 10-Q · filed 2025-11-17 | ||
| 2025-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-16 | $0.00 derived: sum of 2 quarters · filed 2026-06-16 | $0.00 10-Q · filed 2026-06-16 |
| 2024-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-17 | $0.00 10-Q · filed 2026-03-17 | |
| 2024-08-31 | $0.00 10-Q · filed 2025-11-17 | ||
| 2024-02-29 | $0.00 10-Q · filed 2025-04-24 |